Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)
The purpose of this phase II trial is to evaluate the efficacy of adding high-dose ascorbate (vitamin C) to the standard of care regimen for metastatic pancreatic adenocarcinoma.
Study ID: 201801759
Trial Phase: Phase II
Trial Sponsor: University of Iowa
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Ascorbic Acid